World's Best Scientists 2026 revealed!
Kazuyoshi Takeda

Kazuyoshi Takeda

D-Index & Metrics

Immunology

D-Index
84
Citations
23279
World Ranking
1394
National Ranking
55

Medicine

D-Index
84
Citations
23281
World Ranking
15215
National Ranking
470

Kazuyoshi Takeda publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Kazuyoshi Takeda sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 208 publications — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Kazuyoshi Takeda D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Kazuyoshi Takeda sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 84 D-Index — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Kazuyoshi Takeda is affiliated with Juntendo University in Japan, contributing extensively to research in Medicine and Immunology and Microbiology. Their work spans several subfields including Immunology, Oncology, Clinical Psychology, General Health Professions, and Surgery.

Their scholarly output encompasses a variety of topics, with main research interests including:

  • COVID-19 and Mental Health
  • Immunotherapy and Immune Responses
  • Immune Cell Function and Interaction
  • Cancer Immunotherapy and Biomarkers
  • Healthcare professionals' stress and burnout
  • CAR-T cell therapy research
  • Organ Transplantation Techniques and Outcomes

Takeda has published numerous papers in different scientific journals. Some recent works include:

  • "An IL-12-Based Nanocytokine Safely Potentiates Anticancer Immunity through Spatiotemporal Control of Inflammation to Eradicate Advanced Cold Tumors", 2023, Advanced Science
  • "COVID-19-related discrimination, PTSD symptoms, and psychological distress in healthcare workers", 2022, International Journal of Mental Health Nursing
  • "Sex Differences in Social Cognition and Association of Social Cognition and Neurocognition in Early Course Schizophrenia", 2022, Frontiers in Psychology
  • "Association of COVID-19-related discrimination with subsequent depression and suicidal ideation in healthcare workers", 2023, Journal of Psychiatric Research
  • "Inhibition of Importin β1 Augments the Anticancer Effect of Agonistic Anti-Death Receptor 5 Antibody in TRAIL-resistant Tumor Cells", 2020, Molecular Cancer Therapeutics

Frequent coauthors with whom Takeda has collaborated include:

  • Ko Okumura
  • Ryo Okubo
  • Koichiro Uchida
  • Yohei Sasaki
  • Hideki Oi

The majority of Takeda's publications appear in several key venues, with the most frequent being:

  • Biomedical Research
  • Scientific Reports
  • Transplantation
  • Advanced Science
  • Frontiers in Psychology

Best Publications

  • Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells.

    Kazuyoshi Takeda;Yoshihiro Hayakawa;Mark J. Smyth;Nobuhiko Kayagaki

  • Activation of NK cell cytotoxicity.

    Mark J. Smyth;Erika Cretney;Janice M. Kelly;Jennifer A. Westwood

  • Improved efficacy of neoadjuvant compared to adjuvant immunotherapy to eradicate metastatic disease

    Jing Liu;Jing Liu;Stephen J. Blake;Michelle C.R. Yong;Heidi Harjunpää;Heidi Harjunpää

  • Sequential production of interferon-gamma by NK1.1( ) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide

    MJ Smyth;NY Crowe;DG Pellicci;K Kyparissoudis

  • Critical contribution of liver natural killer T cells to a murine model of hepatitis.

    Kazuyoshi Takeda;Yoshihiro Hayakawa;Luc Van Kaer;Hironori Matsuda

  • Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail) Contributes to Interferon γ–Dependent Natural Killer Cell Protection from Tumor Metastasis

    Mark J. Smyth;Erika Cretney;Kazuyoshi Takeda;Robert H. Wiltrout

  • Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells

    Yulong Gao;Yulong Gao;Fernando Souza-Fonseca-Guimaraes;Fernando Souza-Fonseca-Guimaraes;Fernando Souza-Fonseca-Guimaraes;Tobias Bald;Susanna S Ng;Susanna S Ng

  • Critical Role for Tumor Necrosis Factor–related Apoptosis-inducing Ligand in Immune Surveillance Against Tumor Development

    Kazuyoshi Takeda;Mark J. Smyth;Erika Cretney;Yoshihiro Hayakawa

  • Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation.

    Masafumi Nakayama;Hisaya Akiba;Kazuyoshi Takeda;Yuko Kojima

  • Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells.

    Nobuhiko Kayagaki;Noriko Yamaguchi;Masafumi Nakayama;Kazuyoshi Takeda

  • The Role of ICOS in the CXCR5+ Follicular B Helper T Cell Maintenance In Vivo

    Hisaya Akiba;Kazuyoshi Takeda;Yuko Kojima;Yoshihiko Usui

  • Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells

    Toshiro Futagawa;Hisaya Akiba;Tomohiro Kodama;Kazuyoshi Takeda

  • NKT cells — conductors of tumor immunity?

    Mark J Smyth;Nadine Y Crowe;Yoshihiro Hayakawa;Kazuyoshi Takeda

  • Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses

    Arabella Young;Arabella Young;Shin Foong Ngiow;Shin Foong Ngiow;Deborah S. Barkauskas;Erin Sult

  • Eradication of established tumors in mice by a combination antibody-based therapy.

    Tomoyasu Uno;Kazuyoshi Takeda;Kazuyoshi Takeda;Yuko Kojima;Hirohisa Yoshizawa

  • Critical Contribution of Ox40 Ligand to T Helper Cell Type 2 Differentiation in Experimental Leishmaniasis

    Hisaya Akiba;Yasushi Miyahira;Machiko Atsuta;Kazuyoshi Takeda

  • Antiviral response by natural killer cells through TRAIL gene induction by IFN–α/β

    Kojiro Sato;Shigeaki Hida;Hiroshi Takayanagi;Taeko Yokochi

  • The Dark Side of IFN-γ: Its Role in Promoting Cancer Immunoevasion

    Marija Mojic;Kazuyoshi Takeda;Yoshihiro Hayakawa

  • TRAIL and its receptors as targets for cancer therapy.

    Hideo Yagita;Kazuyoshi Takeda;Yoshihiro Hayakawa;Mark J. Smyth

  • Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice.

    S Toyabe;S Seki;T Iiai;K Takeda

  • Plasmodium berghei Infection in Mice Induces Liver Injury by an IL-12- and Toll-Like Receptor/Myeloid Differentiation Factor 88-Dependent Mechanism

    Keishi Adachi;Hiroko Tsutsui;Shin-Ichiro Kashiwamura;Ekihiro Seki

Frequent Co-Authors

Ko Okumura
Ko Okumura Juntendo University
Hideo Yagita
Hideo Yagita Juntendo University
Mark J. Smyth
Mark J. Smyth QIMR Berghofer Medical Research Institute
Yoshihiro Hayakawa
Yoshihiro Hayakawa Aichi Institute of Technology
Michele W. L. Teng
Michele W. L. Teng QIMR Berghofer Medical Research Institute
Hisaya Akiba
Hisaya Akiba Juntendo University
Roy J. Shephard
Roy J. Shephard University of Toronto
Yusuke Nakamura
Yusuke Nakamura National Institutes of Biomedical Innovation, Health and Nutrition
Kouetsu Ogasawara
Kouetsu Ogasawara Tohoku University
Tatsuro Irimura
Tatsuro Irimura Juntendo University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in branching out from Immunology into healthcare, nursing offers a variety of online educational paths that blend well with a scientific background. Many students benefit from exploring online accelerated nursing programs for non nurses, which are designed to swiftly transition individuals without prior nursing experience into professional roles.

Within these options, some students prioritize programs with more accessible admission criteria. Resources like the list of easiest accelerated nursing programs help prospective students identify flexible and welcoming programs that fit their needs without compromising quality.

For those seeking entry-level positions or aiming to build foundational nursing skills, exploring easy LPN programs to get into can be a practical step. These programs generally have straightforward prerequisites and offer pathways to gain valuable clinical experience.

Advancing beyond initial licensure, many consider becoming a nurse practitioner. Understanding which nurse practitioner program is easiest can be crucial for balancing career progression with personal commitments, allowing for efficient and manageable graduate studies.

Best Scientists Citing Kazuyoshi Takeda

Trending Scientists